RCOR1 and acute myeloid leukemia: Taken together, these analyses demonstrate that the strongest binding peaks for GFI1, LSD1, and RCOR1 in THP1 AML cells are coincident with one another and that pharmacologic inhibition of LSD1 in particular targets GFI1/CoREST chromatin-bound complexes for disruption and release to the nucleoplasm.